News
Vertex Pharmaceuticals is expected to outshine projections when it reports Q1 2025 earnings, with strong sales from its ...
Zacks Investment Research on MSN2d
Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?We expect Vertex Pharmaceuticals Incorporated VRTX to surpass expectations when it reports first-quarter 2025 results on May ...
New non-opioid pain killer get FDA approval for acute pain. Patients are taking note. Also demonstrated efficacy, just not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback